Nectar Lifescience Share Price

Nectar Lifesci.

CMP as on 17-May-22 12:14

₹ 25.40
0.25 0.99%

Open

₹ 25.50

Turnover (lac)

₹ 50

Prev. Close

₹ 25.15

Day's Vol (shares)

₹ 1,96,190

Day's Range (₹)

₹ 25.10
₹ 25.90

CMP as on17-May-22 12:13

₹ 25.40
0.15 0.59%

Open

₹ 25.40

Turnover (lac)

₹ 14

Prev. Close

₹ 25.25

Day's Vol (shares)

₹ 65,248

Day's Range

₹ 25.00
₹ 26.00

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 07-Feb-2022 - -
NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 inter alia to consider and approve the Unaudited Financial results for the quarter and nine months ended on December 31 2021. The Board of Directors of the Company at their meeting held today duly approved and took on record the limited reviewed Unaudited Standalone and Consolidated Financial results for the quarter and nine month ended on December 31, 2021, which are enclosed herewith along with the Limited Review Reports of the Auditors thereon. (As Per BSE Announcement Dated 14.02.2022)
Board Meeting - 03-Nov-2021 - -
Quarterly Results The Board of Directors of the Company at their meeting held today duly approved and took on record the limited reviewed Unaudited Standalone and Consolidated Financial results for the quarter and half year ended on September 30, 2021, which are enclosed herewith along with the Limited Review Reports of the Auditors thereon. (As Per BSE Announcement dated on 13.11.2021)
Board Meeting - 07-Aug-2021 - -
NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2021 inter alia to consider and approve Pursuant to Regulations 29 30 33 and other applicable Regulations of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the company will be held on Saturday August 14 2021 to consider and approve inter alia amongst items the Unaudited Financial Results for the quarter ended on June 30 2021. Limited reviewed Unaudited Standalone & Consolidated Financial results for the quarter ended on June 30, 2021, which are enclosed herewith along with the Limited Review Reports of the Auditors thereon. NECLIFE : Nectar Lifesciences Limited has informed the Exchange regarding Board meeting held on August 14, 2021 in which it is, inter alia, it has been decided to propose to members to appoint Dr. Kuldip Kumar Bhasin (DIN 0009250008) on the Board as an Independent Director of the company in the forthcoming Annual General Meeting to be held on September 21, 2021 (AGM). His term will be of five years in case he gets appointed in the AGM. The relevant disclosures in this regard are attached. (As Per BSE Announcement Dated 14.08.2021)
Board Meeting - 17-Jul-2021 - -
NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2021 ,inter alia, to consider and approve We wish to inform you that meeting of Board of Directors of the company will be held on July 23, 2021 to consider and approve, inter alia amongst items: 1. The Audited Financial Results for the Financial Year 2020-21, Financial Statements of the Company for the Financial Year 2020-21 and matters related thereto. 2. To Convene the Annual General Meeting of Members of the Company for the Financial Year 2020-21 and matters related thereto. 3. To fix Book Closure dates for the purpose of Annual General Meeting. Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2021 and Outcome of Board Meeting as per attached letter The Board of Directors in their meeting held on July 23, 2021 have in-principal approved the sale of Non Core Assets/ Core Assets which are unproductive/ less productive. The proceeds from sales of above assets will be used for repayment of Bank Loans. This is to inform you that the Board of Directors of the Company in their meeting held on July 23, 2021 have appointed Ms. Anubha (ACS 47868) as a Company Secretary & Compliance Officer of the Company with effect from August 01, 2021. (AS Per BSE Announcement Dated on 23.07.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity